Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tinnitus suppression in patients with cochlear implants.

M J Ruckenstein1, C Hedgepeth, K O Rafter

  • 1Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania, Philadelphia 19104, USA.

Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology
|April 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis B reactivation in people living with HIV and isolated anti-HBc receiving tenofovir-sparing dual antiretroviral therapy.

HIV medicine·2026
Same author

Review and statistical analysis of activity values reported for coastal sands worldwide.

Chemosphere·2024
Same author

Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV-1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study.

HIV medicine·2024
Same author

Three-year efficacy of switching to dolutegravir plus lamivudine: A real-world study.

HIV medicine·2023
Same author

Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.

HIV medicine·2023
Same author

Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD.

Frontiers in pharmacology·2022

Multichannel cochlear implants significantly reduce tinnitus in 92% of patients. These devices offer effective tinnitus suppression without worsening symptoms, regardless of patient gender or speech recognition ability.

Area of Science:

  • Otolaryngology
  • Neuroscience
  • Biomedical Engineering

Background:

  • Tinnitus is a common and often debilitating condition associated with severe-to-profound hearing loss.
  • Cochlear implantation is a primary treatment for hearing loss, but its effect on tinnitus is of significant interest.

Purpose of the Study:

  • To evaluate the efficacy of multichannel cochlear implants in suppressing tinnitus.
  • To identify factors influencing tinnitus reduction post-implantation.

Main Methods:

  • A prospective cohort study involving 38 adult patients with hearing loss and tinnitus undergoing cochlear implantation.
  • Tinnitus intensity was assessed using a semiquantitative scale before and after implantation.
  • Analysis included speech recognition, patient gender, and implant type as potential influencing factors.

Related Experiment Videos

Main Results:

  • A significant reduction in tinnitus intensity was observed in 92% (35 of 38) of patients post-implantation.
  • All studied multichannel cochlear implant devices provided similar tinnitus suppression.
  • Tinnitus reduction was not correlated with speech recognition scores; gender did not impact post-implantation tinnitus levels.

Conclusions:

  • Multichannel cochlear implants effectively suppress tinnitus in the majority of patients.
  • Cochlear implantation does not pose a significant risk of tinnitus exacerbation.
  • The precise mechanisms underlying cochlear implant-mediated tinnitus suppression remain to be elucidated.